Literature DB >> 16689773

Measurement of ADAMTS-13 activity in plasma by the FRETS-VWF73 assay: comparison with other assay methods.

J A Kremer Hovinga, M Mottini, B Lämmle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16689773     DOI： 10.1111/j.1538-7836.2006.01904.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  25 in total

1.  Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.

Authors:  Sumit Som; Cassandra C Deford; Mandi L Kaiser; Deirdra R Terrell; Johanna A Kremer Hovinga; Bernhard Lämmle; James N George; Sara K Vesely
Journal:  Transfusion       Date:  2012-04-15       Impact factor: 3.157

2.  Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis.

Authors:  Frank C Vandy; Cathy Stabler; Anna M Eliassen; Angela E Hawley; Kenneth E Guire; Daniel D Myers; Peter K Henke; Thomas W Wakefield
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-04-01

Review 3.  Clinical and laboratory diagnosis of TTP: an integrated approach.

Authors:  Thita Chiasakul; Adam Cuker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 4.  Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.

Authors:  Minola Manea; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2008-09-20       Impact factor: 3.714

Review 5.  Thrombotic microangiopathies: a general approach to diagnosis and management.

Authors:  Donald M Arnold; Christopher J Patriquin; Ishac Nazy
Journal:  CMAJ       Date:  2016-10-17       Impact factor: 8.262

6.  Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.

Authors:  Sam L Ivry; Jeremy M Sharib; Dana A Dominguez; Nilotpal Roy; Stacy E Hatcher; Michele T Yip-Schneider; C Max Schmidt; Randall E Brand; Walter G Park; Matthias Hebrok; Grace E Kim; Anthony J O'Donoghue; Kimberly S Kirkwood; Charles S Craik
Journal:  Clin Cancer Res       Date:  2017-04-19       Impact factor: 12.531

7.  Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.

Authors:  Tobias A Fuchs; Johanna A Kremer Hovinga; Daphne Schatzberg; Denisa D Wagner; Bernhard Lämmle
Journal:  Blood       Date:  2012-05-18       Impact factor: 22.113

8.  Systemic infections mimicking thrombotic thrombocytopenic purpura.

Authors:  Kristina K Booth; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

9.  An optimized fluorogenic ADAMTS13 assay with increased sensitivity for the investigation of patients with thrombotic thrombocytopenic purpura.

Authors:  J Muia; W Gao; S L Haberichter; L Dolatshahi; J Zhu; L A Westfield; S C Covill; K D Friedman; J E Sadler
Journal:  J Thromb Haemost       Date:  2013-08       Impact factor: 5.824

10.  Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage protease.

Authors:  Zuben E Sauna; Chinyere Okunji; Ryan C Hunt; Tanvi Gupta; Courtni E Allen; Elizabeth Plum; Adam Blaisdell; Vahan Grigoryan; S Geetha; Robert Fathke; Kenji Soejima; Chava Kimchi-Sarfaty
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.